Cyclophosphamide/thiotepa/mitoxantrone with autologous stem cell rescue for high risk stage II and stage III breast cancer

被引：0
|
作者：
Krüger, WH [1 ]
Kröger, N [1 ]
Königmann, M [1 ]
Berdel, WE [1 ]
Fuss, H [1 ]
Schultze, W [1 ]
Gieseking, F [1 ]
Schäfer-Eckart, K [1 ]
Möbus, V [1 ]
Frickhofen, N [1 ]
Wandt, H [1 ]
Illiger, HJ [1 ]
Metzner, B [1 ]
Kolbe, K [1 ]
Wörmann, B [1 ]
Trümper, L [1 ]
Huber, C [1 ]
Maass, H [1 ]
Jonat, W [1 ]
Zander, AR [1 ]
机构：
[1] Univ Hamburg, Hosp Eppendorf, Dept Hematol Oncol, BMT, D-20246 Hamburg, Germany
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 22卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
SP31
引用
收藏
页码：S18 / S20
页数：3
相关论文
共 50 条
  • [1] High-dose mitoxantrone-vinblastine-cyclophosphamide and autologous stem cell transplantation for stage III breast cancer: final results of a prospective multicentre study
    Stewart, DA
    Paterson, AHG
    Ruether, JD
    Russell, J
    Craighead, P
    Smylie, M
    Mackey, J
    ANNALS OF ONCOLOGY, 2005, 16 (09) : 1463 - 1468
  • [2] Thiotepa, mitoxantrone and carboplatin (TMJ) and autologous hematopoietic stem cell transplantation in patients with stage II and IIIa breast cancer: An analysis of 116 patients.
    Kancherla, RR
    Ahmed, T
    Qureshi, Z
    Lo, S
    Mittelman, A
    Chun, H
    Puccio, C
    Seiter, K
    BLOOD, 2000, 96 (11) : 424A - 424A
  • [3] Pharmacokinetics of thiotepa and mitoxantrone in high-dose chemotherapy with autologous stem cell support of patients with high-risk breast cancer
    Wolkewitz, B
    Hilger, RA
    Skorzec, M
    Markus-Matulla, A
    Mayer, S
    Steiniger, H
    Schneemann, H
    Seeber, S
    Scheulen, ME
    BONE MARROW TRANSPLANTATION, 1998, 22 : S60 - S64
  • [4] HIGH-DOSE THIOTEPA AND MITOXANTRONE (MITT) FOLLOWED BY AUTOLOGOUS STEM-CELL RESCUE (ASCR) FOR REFRACTORY CANCER
    FIELDS, K
    ELFENBEIN, G
    HIEMENZ, J
    ZORSKY, P
    PERKINS, J
    GONZALEZ, J
    GREENE, S
    OELSLAGER, P
    KRONISH, L
    HOLCOMB, D
    MACHAK, M
    SULLIVAN, P
    PACH, L
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 714 - 714
  • [5] Low morbidity and no mortality of high-dose cyclophosphamide, thiotepa and mitoxantrone plus autologous peripheral blood stem cell support for high-risk breast cancer patients
    Kröger, N
    Krüger, WH
    Gieseking, F
    Jaenicke, F
    Schultze, W
    Fuss, H
    Möbus, V
    Königsmann, M
    Berdel, WE
    Schäfer-Eckert, K
    Wandt, H
    Metzner, B
    Illiger, HJ
    Frickhofen, N
    Wulf, G
    Wörmann, B
    Kolbe, K
    Hossfeld, DK
    Maas, H
    Jonat, W
    Zander, AR
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S38 - S38
  • [6] High-dose Chemotherapy with Autologous Stem Cell Rescue in Stage IIIB Inflammatory Breast Cancer
    Yalamanchili, Kiran
    Lalmuanpuii, Judy
    Waheed, Faisal
    Farjami, Sassan
    Kancherla, Ram
    Qureshi, Zeeshan
    Hoang, Albert
    Khaled, Yusuf
    Lake, Diana
    Puccio, Carmello
    Chun, Hoo G.
    Seiter, Karen
    Ahmed, Tauseef
    ANTICANCER RESEARCH, 2008, 28 (5B) : 3139 - 3142
  • [7] A PHASE-I-II STUDY OF HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA AND ESCALATING DOSES OF MITOXANTRONE WITH AUTOLOGOUS STEM-CELL RESCUE IN PATIENTS WITH REFRACTORY MALIGNANCIES
    ELLIS, ED
    WILLIAMS, SF
    MOORMEIER, JA
    KAMINER, LS
    BITRAN, JD
    BONE MARROW TRANSPLANTATION, 1990, 6 (06) : 439 - 442
  • [8] Variability in engraftment potential of different peripheral blood stem cell preparations given after cyclophosphamide, thiotepa, and carboplatin for stage II/III breast cancer.
    Elfenbein, G
    Perkins, J
    Janssen, W
    Fields, K
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 107 - 107
  • [9] Results of a prospective study with high-dose etoposide, thiotepa and carboplatin and peripheral blood stem cell rescue for high-risk stage II-IIIA and selected stage IV breast cancer patients
    Gori, S
    Mosconi, AM
    Tabilio, A
    Falzetti, F
    Aristei, C
    Basurto, C
    Cherubini, R
    Latini, P
    Martelli, MF
    Tonato, M
    Colozza, M
    TUMORI, 2001, 87 (03) : 138 - 141
  • [10] High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer
    LA Holmberg
    T Demirer
    S Rowley
    CD Buckner
    G Goodman
    R Maziarz
    J Klarnet
    N Zuckerman
    G Harrer
    R McCloskey
    R Gersh
    R Goldberg
    W Nichols
    A Jacobs
    P Weiden
    P Montgomery
    S Rivkin
    FR Appelbaum
    WI Bensinger
    Bone Marrow Transplantation, 1998, 22 : 651 - 659
12345